Development of technology for producing submicron emulsion of propofol using a high-pressure homogenizer

Objectives. Currently, propofol emulsions are widely used in clinical practice due to their rapid action, low toxicity, and ease of administration, including control of anesthetic depth and rapid recovery of the patient following anesthesia. The market offers drugs from both foreign and domestic manufacturers containing imported pharmaceutical substances. The study set out to develop a technology for obtaining a fat emulsion of propofol for parenteral purposes using a high-pressure homogenizer based on pharmaceutical propofol obtained by alkylation and subsequent decarboxylation of 4-hydroxybenzoic acid, as well as to study the physicochemical properties of the obtained submicron emulsions. Methods . A submicron propofol emulsion was prepared using a high-pressure homogenizer. pH was determined using a pH meter equipped with a combined glass electrode. Particle size and zeta potential of the submicron emulsion were determined on a laser particle analyzer using the dynamic and electrophoretic light-scattering methods, respectively. Quantitative propofol content in the resulting emulsion was determined using high-performance liquid chromatography. Results . Optimal technological parameters of the high-pressure homogenization process were selected. The method of adding the oil phase directly into the high-pressure homogenizer is shown to entail lower time and energy costs as compared to the homogenization method involving a preliminary stage of obtaining a pre-emulsion. The physicochemical characteristics of the obtained submicron emulsions were subsequently determined to correspond to the characteristics required for the original drug Propofol-Lipuro®. Conclusions . The proposed technology for obtaining a submicron propofol emulsion for parenteral use is based on dispersion of the aqueous and oil phases using a high-pressure homogenizer. As a result of the study, it was found that adding the oil phase directly into the high-pressure homogenizer at 20 MPa, including further dispersion at 60 MPa for 8 cycles, is optimal for obtaining a submicron propofol emulsion with the required characteristics.

Authors

Institutions

Publication Details

Journal
Fine Chemical Technologies
Published
2025-09-02
DOI
https://doi.org/10.32362/2410-6593-2025-20-4-297-309
Primary Topic
Thermal and Kinetic Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of technology for producing submicron emulsion of propofol using a high-pressure homogenizer

E. A. Shnyak, A. V. Panov, Herman D. Moshkov, Andrey M. Normov
Fine Chemical Technologies
Thermal and Kinetic Analysis
article

Development of technology for producing submicron emulsion of propofol using a high-pressure homogenizer

E. A. Shnyak, A. V. Panov, Herman D. Moshkov, Andrey M. Normov
article en

Abstract

Objectives. Currently, propofol emulsions are widely used in clinical practice due to their rapid action, low toxicity, and ease of administration, including control of anesthetic depth and rapid recovery of the patient following anesthesia. The market offers drugs from both foreign and domestic manufacturers containing imported pharmaceutical substances. The study set out to develop a technology for obtaining a fat emulsion of propofol for parenteral purposes using a high-pressure homogenizer based on pharmaceutical propofol obtained by alkylation and subsequent decarboxylation of 4-hydroxybenzoic acid, as well as to study the physicochemical properties of the obtained submicron emulsions. Methods . A submicron propofol emulsion was prepared using a high-pressure homogenizer. pH was determined using a pH meter equipped with a combined glass electrode. Particle size and zeta potential of the submicron emulsion were determined on a laser particle analyzer using the dynamic and electrophoretic light-scattering methods, respectively. Quantitative propofol content in the resulting emulsion was determined using high-performance liquid chromatography. Results . Optimal technological parameters of the high-pressure homogenization process were selected. The method of adding the oil phase directly into the high-pressure homogenizer is shown to entail lower time and energy costs as compared to the homogenization method involving a preliminary stage of obtaining a pre-emulsion. The physicochemical characteristics of the obtained submicron emulsions were subsequently determined to correspond to the characteristics required for the original drug Propofol-Lipuro®. Conclusions . The proposed technology for obtaining a submicron propofol emulsion for parenteral use is based on dispersion of the aqueous and oil phases using a high-pressure homogenizer. As a result of the study, it was found that adding the oil phase directly into the high-pressure homogenizer at 20 MPa, including further dispersion at 60 MPa for 8 cycles, is optimal for obtaining a submicron propofol emulsion with the required characteristics.

Fine Chemical TechnologiesVol. 20(4)
Moscow State University of Fine Chemical Technologies (RU), MIREA - Russian Technological University (RU)
Openalex Percentile: Top 83%
Thermal and Kinetic Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.